About this trial
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All people incarcerated at a study site during the intervention period
Disqualifiers
None
Trial design
Sequential
Treatments tested in this trial
NIATx
BehavioralThe Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment.
Treatment groups
Trial outcomes
Primary outcomes
Effectiveness
Number of participants on the PNEP
Secondary outcomes
Bloodborne virus cascade of care
Number of HIV and hepatitis C virus screenings/tests, diagnoses, and treatment initiations, among the total prison population
Enrollment in opioid agonist therapy
The number of people who inject drugs who access opioid agonist therapy among the total prison population
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead sponsor
Yale University
Collaborator
Burnet Institute
Collaborator
Kirby Institute
Collaborator